Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)
China
· Delayed Price · Currency is CNY 4.490
+0.030 (0.67%)
At close: Mar 10, 2026
SHE:300111 Revenue
Zhejiang Sunflower Great Health had revenue of 55.10M CNY in the quarter ending September 30, 2025, a decrease of -20.64%. This brings the company's revenue in the last twelve months to 302.92M, down -8.28% year-over-year. In the year 2024, Zhejiang Sunflower Great Health had annual revenue of 330.37M, down -2.38%.
Revenue (ttm)
302.92M
Revenue Growth
-8.28%
P/S Ratio
19.08
Revenue / Employee
915.16K
Employees
331
Market Cap
5.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 330.37M | -8.05M | -2.38% |
| Dec 31, 2023 | 338.42M | 2.56M | 0.76% |
| Jan 1, 2023 | 335.86M | 38.57M | 12.97% |
| Jan 1, 2022 | 297.29M | 10.33M | 3.60% |
| Dec 31, 2020 | 286.96M | -549.66M | -65.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Jibeier Pharmaceutical | 964.93M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Shandong Sinobioway Biomedicine | 257.74M |
| Chongqing Pharscin Pharmaceutical | 786.51M |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.92B |
| Zhongzhu Healthcare Holding Co.,Ltd | 570.62M |
| ChengDu ShengNuo Biotec | 741.34M |